Health Care

Remdesivir expected to remain effective against omicron variant, Gilead says

After conducting an initial genetic analysis of more than 200 available sequences of the omicron variant, including those from South Africa, Asia and Europe, the biotechnology giant has found no new mutations present in the strain that are expected to alter the viral RNA polymerase compared to previous COVID-19 variants.

States: Sackler family members abusing bankruptcy process

A federal judge should reject a sweeping settlement to thousands of lawsuits against OxyContin maker Purdue Pharma, a group of states said at a hearing Tuesday, arguing that the protections it extends to members of the Sackler family who own the firm are improper.

Moderna, Pfizer, J&J talk omicron response

As COVID-19's new omicron variant has begun to emerge overseas, vaccine makers Moderna, Pfizer and Johnson & Johnson have outlined their respective strategies to tackle the new strain.

Prosecutors in Elizabeth Holmes trial revealed untruths, but did they prove intent?

Over 11 weeks of testimony, prosecutors in Theranos Inc. founder Elizabeth Holmes' trial presented a narrative of a CEO who repeatedly fabricated the successes of her technology as she built a blood-testing startup that ultimately failed. They now have to hope they convinced jurors her behavior rose to the level of criminal fraud.